UroGen Pharma(URGN) - 2019 Q2 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2019 Earnings Conference Call August 12, 2019 8:30 AM ET Company Participants Catherine Bechtold - Director of Corporate Communications & IR Elizabeth Barrett - President, CEO Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - CFO & Secretary Stephen Mullennix - Chief Operating Officer Jeff Bova - Senior Vice President of Commercial Conference Call Participants Paul Choi - Goldman Sachs Boris Peaker - Cowen Ram Selvaraju - H.C. Wainwright Chris Howerton - Jeffer ...